Question 2876 — pharmacy and medicines

Summary

Mr. Joël Aviragnet draws the attention of the Minister of Solidarity and Health to the transmission of information to patients when changing the formula of their treatments. For several weeks, thyroid patients have noticed side effects due to taking the new Levothyrox formula. Since October 2, 2017, the old formula must be available again in pharmacies but it will have taken thousands of testimonials from affected patients so that it can be put on sale again. However, patients very rarely find this medication in their pharmacy. The side effects of the new formula of this drug have had serious consequences on the bodies of patients, sometimes preventing them from assuming their professional and family responsibilities. The monopoly of the laboratory manufacturing this drug deprived patients of any alternative to the treatment prescribed to them. The toll-free number set up by the ANSM could not provide satisfactory answers to patients' questions, which left them even more in disarray. The Ministry of Health announced the end of the monopoly of the laboratory manufacturing this drug and the opening of an information mission in order to better support patients. This serious health problem has pointed out a lack of information and listening to patients. If the ANSM cannot contact patients to inform them of a change in formula for understandable reasons of medical confidentiality, the transmission of information to patients via doctors, pharmacists and health professionals should be more effective in order to avoid new personal tragedies for affected patients. He therefore asks him what measures can be taken as quickly as possible in order to draw the consequences of this Levothyrox crisis, prevent such a tragedy from happening again and finally to ensure that pharmacies are properly supplied.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.